Schwartz Jc

1.7k total citations
48 papers, 1.4k citations indexed

About

Schwartz Jc is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Schwartz Jc has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Immunology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Schwartz Jc's work include Mast cells and histamine (18 papers), Receptor Mechanisms and Signaling (15 papers) and Chemical Synthesis and Analysis (8 papers). Schwartz Jc is often cited by papers focused on Mast cells and histamine (18 papers), Receptor Mechanisms and Signaling (15 papers) and Chemical Synthesis and Analysis (8 papers). Schwartz Jc collaborates with scholars based in France, Germany and Sweden. Schwartz Jc's co-authors include M. Garbarg, JM Arrang, Pierre Sokoloff, H. Pollard, Jorge Díaz, C. Lammers, G. Barbin, Claude P. Gros, Bernard Le Foll and Christiane Rose and has published in prestigious journals such as Journal of Neuroscience, Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Schwartz Jc

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Schwartz Jc France	18	748	534	494	287	204	48	1.4k
José‐Antonio Arias‐Montaño Mexico	20	824 1.1×	680 1.3×	501 1.0×	326 1.1×	127 0.6×	80	1.4k
A. Rouleau France	21	1.1k 1.5×	1.3k 2.5×	291 0.6×	576 2.0×	265 1.3×	38	1.9k
Florence Gbahou France	20	1.1k 1.5×	1.0k 1.9×	417 0.8×	474 1.7×	191 0.9×	36	1.8k
T. Watanabe Japan	15	403 0.5×	498 0.9×	255 0.5×	296 1.0×	155 0.8×	25	997
Junichi Kitanaka Japan	22	759 1.0×	188 0.4×	693 1.4×	100 0.3×	162 0.8×	85	1.5k
Motohiko Takemura Japan	20	650 0.9×	203 0.4×	520 1.1×	107 0.4×	108 0.5×	70	1.3k
Motohisa Kato Japan	19	217 0.3×	282 0.5×	165 0.3×	230 0.8×	189 0.9×	28	970
Elizabeth P. Seward United Kingdom	23	1.1k 1.5×	123 0.2×	657 1.3×	159 0.6×	246 1.2×	34	1.8k
Claas A. Meyer Switzerland	13	690 0.9×	180 0.3×	561 1.1×	96 0.3×	164 0.8×	19	1.2k
Stephen J. Bunn Australia	24	616 0.8×	144 0.3×	521 1.1×	51 0.2×	204 1.0×	67	1.6k

Countries citing papers authored by Schwartz Jc

Since Specialization

Citations

This map shows the geographic impact of Schwartz Jc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schwartz Jc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schwartz Jc more than expected).

Fields of papers citing papers by Schwartz Jc

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Schwartz Jc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schwartz Jc. The network helps show where Schwartz Jc may publish in the future.

Co-authorship network of co-authors of Schwartz Jc

This figure shows the co-authorship network connecting the top 25 collaborators of Schwartz Jc. A scholar is included among the top collaborators of Schwartz Jc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Schwartz Jc. Schwartz Jc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Perrin, David, et al.. (2013). Preclinical evaluation of the abuse potential ofPitolisant, a histamineH₃receptor inverse agonist/antagonist compared withModafinil. British Journal of Pharmacology. 169(3). 632–644. 46 indexed citations

Ligneau, Xavier, David Perrin, Laurent Landais, et al.. (2006). BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, Hydrochloride], a Nonimidazole Inverse Agonist/Antagonist at the Human Histamine H3 Receptor: Preclinical Pharmacology. Journal of Pharmacology and Experimental Therapeutics. 320(1). 365–375. 192 indexed citations

Funalot, Benoît, Tanja Ouimet, Audrey Clapéron, et al.. (2004). Endothelin-converting enzyme-1 is expressed in human cerebral cortex and protects against Alzheimer's disease. Molecular Psychiatry. 9(12). 1122–1128. 49 indexed citations

Foll, Bernard Le, Schwartz Jc, & Pierre Sokoloff. (2003). Disruption of nicotine conditioning by dopamine D3 receptor ligands. Molecular Psychiatry. 8(2). 225–230. 71 indexed citations

Morisset‐Lopez, Séverine, et al.. (2000). Histamine H2 receptor gene variants: lack of association with schizophrenia. Molecular Psychiatry. 5(2). 159–164. 30 indexed citations

Lammers, C., Jorge Díaz, Schwartz Jc, & Pierre Sokoloff. (2000). Dopamine D3 receptor gene expression in the shell of nucleus accumbens is increased by chronic antidepressant treatment. Molecular Psychiatry. 5(3). 229–229. 13 indexed citations

Lammers, C., Jorge Díaz, Schwartz Jc, & Pierre Sokoloff. (2000). Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments. Molecular Psychiatry. 5(4). 378–388. 131 indexed citations

Krebs, Marie‐Odile, François Sautel, Pierre Sokoloff, et al.. (1998). Dopamine D3 receptor gene variants and substance abuse in schizophrenia. Molecular Psychiatry. 3(4). 337–341. 59 indexed citations

Jc, Schwartz, Sophie Ridray, Régis Bordet, Jorge Díaz, & Pierre Sokoloff. (1997). DI/D3 Receptor Relationships in Brain Coexpression, Coactivation, and Coregulation. Advances in pharmacology. 42. 408–411. 16 indexed citations

10.

Stark, Holger, et al.. (1997). Search for novel leads for histamine H3-receptor antagonists: amine derivatives.. PubMed. 52(6). 419–23. 1 indexed citations

11.

Lipp, Ralph, Holger Stark, JM Arrang, et al.. (1995). Synthesis and histamine H3-receptor agonist activity of mono- and dialkyl-substituted histamine derivatives. European Journal of Medicinal Chemistry. 30(3). 219–225. 3 indexed citations

12.

Sokoloff, Pierre, Nathalie Griffon, Caroline Pilon, et al.. (1994). S25. New discoveries in dopamine (supported by an educational grant from Astra S). European Psychiatry. 9(S1). 54s–55s. 1 indexed citations

13.

Jc, Schwartz, et al.. (1993). [Action of acetorphan, an enkephalinase inhibitor, in acute diarrhea].. PubMed. 28(6-7). 279–85. 1 indexed citations

14.

Lévesque, Daniel, et al.. (1992). THE DOPAMINE D3 RECEPTOR AS A KEY TARGET FOR ANTIPSYCHOTICS. Clinical Neuropharmacology. 15. 456A–457A. 10 indexed citations

15.

Arrang, JM, M. Garbarg, & Schwartz Jc. (1987). Autoinhibition of histamine synthesis mediated by presynaptic H3-receptors. Neuroscience. 23(1). 149–157. 238 indexed citations

16.

Giros, Bruno, Claude P. Gros, Catherine Llorens‐Cortés, & Schwartz Jc. (1987). [Opioid peptides: metabolism and receptors].. PubMed. 11(3 Pt 2). 7B–13B. 1 indexed citations

17.

Jc, Schwartz, et al.. (1980). Histamine receptors in the brain: characterization by binding studies and biochemical effects.. PubMed. 21. 169–82. 17 indexed citations

18.

Jc, Schwartz, H. Pollard, Catherine Llorens‐Cortés, et al.. (1978). Endorphins and endorphin receptors in striatum: relationships with dopaminergic neurons.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 18. 245–64. 50 indexed citations

19.

Garbarg, M., et al.. (1978). Pharmacological characterization of histamine receptors mediating the stimulation of cyclic AMP accumulation in slices from guinea-pig hippocampus.. Molecular Pharmacology. 14(6). 971–982. 80 indexed citations

20.

Jc, Schwartz, et al.. (1976). Neurochemical evidence for histamine acting as a transmitter in mammalian brain.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 15. 111–26. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact